← All organizations

Meissa Vaccines, Inc.

For profitWebsite ↗

Also known as: Meissa Vaccines, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 3, 2021

Timeline

2010s

Jan 1, 2014
Meissa Vaccines, Inc.— Founded

Drugs by trial phase (2 distinct, 5 trials)

Phase 2 (1 own, 0 via acquisition)

mv-012-968

Phase 1 (1 own, 0 via acquisition)

mv-014-212

Indications

Studied for

Recent trials (10)

NCT04909021Study directorPhase 1Jun 3, 2021
NCT04909021Lead sponsorPhase 1Jun 3, 2021
NCT04798001Study directorPhase 1Apr 12, 2021
NCT04798001Lead sponsorPhase 1Apr 12, 2021
NCT04690335Lead sponsorPhase 2Dec 29, 2020
NCT04690335Study directorPhase 2Dec 29, 2020
NCT04444284Study directorPhase 1Jun 9, 2020
NCT04444284Lead sponsorPhase 1Jun 9, 2020
NCT04227210Lead sponsorPhase 1Jan 31, 2020
NCT04227210Study directorPhase 1Jan 31, 2020

Details

Founded: San Francisco, CA, US Jan 1, 2014
Last known activity: Jun 3, 2021